NCT02194881View on ClinicalTrials.gov

Ivacaftor in French Patients With Cystic Fibrosis and a G551D Mutation

CompletedOBSERVATIONAL
Enrollment

57

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

May 31, 2016

Conditions
Cystic Fibrosis
Interventions
DRUG

CF patients with a G551D mutation and treated with Ivacaftor

Trial Locations (1)

75014

Hôpital Cochin, Paris

All Listed Sponsors
collaborator

Vaincre la Mucoviscidose

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02194881 - Ivacaftor in French Patients With Cystic Fibrosis and a G551D Mutation | Biotech Hunter | Biotech Hunter